Skip to content

Preliminary results from a community-based ayahuasca-assisted mental health program among a Yaqui Indigenous population in Sonora, Mexico

Cecile Giovannetti, Anja Loizaga-Velder, Ricardo Campoy Gomez, García Friginal Jaime, Teresa Castillo Valenzuela, Guadalupe Sánchez, Olivia Marcus, Gabrielle Agin-Liebes, Brian Rush

Journal of Psychedelic Studies January 24, 2025 DOI: 10.1556/2054.2024.00401 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational pilot study Peer reviewed
Sample size 37
Population Yaqui Indigenous patients diagnosed with depression, anxiety, complicated grief, or substance use disorder
Interventions Ayahuasca ceremonies psychotherapeutic support
Topics Ayahuasca
Keywords Indigenous Mental health Population Gerontology Demography
Citations 5
Key findings Patients showed marked reductions in depression, anxiety, complicated grief, suicidality, and PTSD symptoms after ayahuasca ceremonies integrated with psychotherapeutic support.

Abstract

Abstract Background The Yaqui Intercultural Medicine Clinic was established in 2020 to provide accessible, culturally-attuned treatment for substance use and mental health disorders among an Indigenous Yaqui community in Mexico. The treatment program integrates ayahuasca ceremonies and psychotherapeutic support within a community-based outpatient treatment service. This observational pilot study was conducted to evaluate the safety, short-term symptom improvement, and cultural implications of the clinic's program.

Methods: Data from 37 patients who were diagnosed with depression, anxiety, complicated grief, or substance use disorder were included in the analysis. Patients were included in the study if they participated in at least one ayahuasca session with psychotherapeutic support. Data were collected using the Mini International Neuropsychiatric Interview (MINI), Beck Depression Inventory (BDI-II), Beck Anxiety Inventory (BAI), Index for Complicated Grief (ICG), and the Post-Traumatic Stress Checklist for DSM-5 (PCL-5).

Results: Patients demonstrated marked reductions in scores of depression, anxiety, complicated grief, suicidality, and PTSD symptoms following ayahuasca ceremonies. After two ceremonies, mean BDI-II scores dropped from 15.7 to 5.1, mean BAI scores dropped from 16.6 to 6.3, and ICG scores reduced from 39.6 to 10.7. Among eight patients presenting suicide risk, seven cases resolved following a single ayahuasca ceremony. Safety assessment indicated that ayahuasca ceremonies were well-tolerated.

Conclusions: Preliminary data suggest that ayahuasca ceremonies integrated within a culturally-attuned community-based mental health program show promise for rapidly reducing mental health symptoms among a small group of Yaqui patients. These findings support further research of community-based ayahuasca-assisted therapeutic programs for mental health treatment within Indigenous communities.

Comparable studies

Other non-randomized and open-label trials on ayahuasca, most cited first.

Study Year Design Participants
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression Patients with recurrent depression 2015 Open-label trial n = 17
Assessing the Psychedelic “After-Glow” in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities Healthy volunteers 2017 Open-label uncontrolled study n = 16
Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial. Individuals with recurrent major depressive disorder 2021 Open-label trial (secondary analysis) n = 17
Pilot Evaluation of a Residential Drug Addiction Treatment Combining Traditional Amazonian Medicine, Ayahuasca and Psychotherapy on Depression and Anxiety Male patients in an inpatient addiction treatment program 2020 Pre-post observational study n = 31
Long-term effects of ayahuasca in patients with recurrent depression: a 5-year qualitative follow-up Patients with treatment-resistant major depressive disorder who had participated in an... 2018 Long-term follow-up of an open-label trial n = 8

Citations in the library

Cited by 6

and 1 more in the library

Cites 29

and 24 more in the library

Explore topics